HistoSonics announced that its Edison histotripsy system for noninvasively destroying liver tumors has secured early U.K.

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping ...

Abbott (NYSE: ABT) published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless ...

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

The Financial Times reported yesterday that a duo of private equity firms approached Hologic (Nasdaq: HOLX) about a potential ...

Inspire Medical Systems (NYSE: INSP) announced that it recently launched the EuroStim registry evaluating its technology in ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Empatica announced today that it received CE mark approval for its EpiMonitor epilepsy monitoring solution. EpiMonitor, a ...

Distalmotion received FDA 510(k) clearance for the use of its Dexter surgical robot in adult cholecystectomy (gallbladder ...

BD (NYSE: BDX) announced today that it plans to initiate a patient data registry for its Rotarex atherectomy system.